Search

Saved articles

You have not yet added any article to your bookmarks!

Newsletter image

Subscribe to the Newsletter

Join 10k+ people to get notified about new posts, news and tips.

Do not worry we don't spam!

Ozempic Patent Ends, Cheap Copies Set For India

Ozempic Patent Ends, Cheap Copies Set For India

Post by : Shakul

The global market for obesity medicines could see a major shift as the patent for semaglutide — the key ingredient used in popular drugs Ozempic and Wegovy — is set to expire in India later this month.

The medicine, originally developed by Danish pharmaceutical company Novo Nordisk, has become one of the most widely discussed treatments for obesity and type-2 diabetes worldwide.

With the patent protection ending on March 20 in India, several pharmaceutical companies including Mankind Pharma, Ajanta Pharma, Sun Pharmaceutical Industries and Lupin Limited are preparing to introduce generic versions of the drug.

These generic versions are expected to cost significantly less than the branded therapies currently sold by Novo Nordisk, potentially reducing treatment prices by around 40% to 50%.

Healthcare providers and clinics are already preparing for increased demand for obesity treatment as cheaper medicines become available. Hospitals and digital health platforms are expanding services related to weight management, diet counselling and long-term monitoring for patients using these drugs.

According to estimates from CareEdge Ratings, the market for GLP-1 based obesity medicines in India could grow rapidly over the next decade as more patients seek treatment for weight-related health conditions.

The demand is also driven by rising metabolic disorders such as diabetes, thyroid disease and fatty liver, which are increasingly linked to sedentary lifestyles and high-calorie diets.

Globally, the adoption of obesity drugs has followed different models. In the United States, telehealth platforms have helped drive demand for these medicines, while in China online pharmacies and digital healthcare services have played a key role in distribution.

Experts say India could become an important test market for the impact of generic competition on anti-obesity drugs, potentially influencing global pricing trends if cheaper versions gain widespread adoption.

The expansion of these medicines may also encourage healthcare providers to develop integrated obesity treatment programmes combining medication, diagnostics and lifestyle management.

March 16, 2026 12:41 p.m. 608

#Business News #Survival #Lifestyle #Newsible Asia

Singapore Reviews New US Chip Export Controls Targeting China
Nov. 17, 2026 11:34 a.m.
Singapore reviews US chip export restrictions targeting China's AI access, raising concerns for semiconductor trade and data centre businesses
Read More
APEC Members Emphasise Safe and Responsible Use of Artificial Intelligence
Nov. 17, 2026 10:24 a.m.
APEC members discuss responsible AI use, digital innovation and data governance as China and the US compete for global AI leadership
Read More
Union of European Clubs Challenge UEFA and EFC Over EU Competition Rules
Nov. 16, 2026 5:18 p.m.
UEC files an EU competition complaint against UEFA and EFC, challenging club representation, governance rights and decision-making powers
Read More
US Dollar Extends Rally as Yen Faces Pressure After Weak GDP
Nov. 16, 2026 4:29 p.m.
The US dollar reaches a 19-month high as traders assess Fed rate signals, weak Japan GDP data and possible yen intervention
Read More
Sheikh Hasina Plans December Return to Bangladesh Despite Death Threat
Nov. 16, 2026 3:35 p.m.
Sheikh Hasina plans to return to Bangladesh in December despite death threats, a death sentence and growing political tensions with Dhaka
Read More
Trump Plans to Name Nvidia and AI Firms US National Champions
Nov. 16, 2026 10:01 a.m.
Trump administration plans to name Nvidia, Amazon, Microsoft and OpenAI among US AI national champions to expand overseas and compete with China
Read More
Mohammed Shami Retires From Test Cricket, Eyes White-Ball Career
Nov. 7, 2026 11:10 a.m.
Mohammed Shami retires from Test cricket after 13 years, with 229 wickets. He will continue playing white-ball cricket and domestic matches
Read More
Najib Razak Leaves Prison to Serve Remaining Sentence at Home
Nov. 6, 2026 2:22 p.m.
Najib Razak leaves Kajang Prison after payment of a RM50 million fine, allowing Malaysia's former PM to serve his remaining sentence at home
Read More
Singapore Warns Users About Privacy and Security Risks of AI Agents
Nov. 6, 2026 12:50 p.m.
Singapore warns users about AI agent security risks, data privacy, online scams and unauthorised access to personal accounts
Read More
Trending News